GE HEALTHCARE TECHNOLOGIES INC. Operating Income
GE HEALTHCARE TECHNOLOGIES INC. (GEHC) reported Operating Income of $515.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-04-29
- GE HEALTHCARE TECHNOLOGIES INC. operating income (loss) for the quarter ending 2026-03-31 was $515.00M, a 18.12% decline year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. operating income (loss) for the quarter ending 2025-12-31 was $827.00M, a 3.25% increase year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. operating income (loss) for the quarter ending 2025-09-30 was $653.00M, a 3.40% decline year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. operating income (loss) for the quarter ending 2025-06-30 was $654.00M, a 7.57% increase year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. operating income (loss) for fiscal 2025 was $2.76B, a 5.26% increase from fiscal 2024.
- GE HEALTHCARE TECHNOLOGIES INC. operating income (loss) for fiscal 2024 was $2.63B, a 7.80% increase from fiscal 2023.
- GE HEALTHCARE TECHNOLOGIES INC. operating income (loss) for fiscal 2023 was $2.44B, a 3.45% decline from fiscal 2022.
- GE HEALTHCARE TECHNOLOGIES INC. operating income (loss) for fiscal 2022 was $2.52B, a 9.77% decline from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-03-31 | $515.00M 10-Q · filed 2026-04-29 | $1.34B derived: sum of 2 quarters · filed 2026-04-29 | $2.00B derived: sum of 3 quarters · filed 2026-04-29 | $2.65B derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $827.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $1.48B derived: sum of 2 quarters · filed 2026-02-04 | $2.13B derived: sum of 3 quarters · filed 2026-02-04 | $2.76B 10-K · filed 2026-02-04 |
| 2025-09-30 | $653.00M 10-Q · filed 2025-10-29 | $1.31B derived: sum of 2 quarters · filed 2025-10-29 | $1.94B 10-Q · filed 2025-10-29 | $2.74B derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $654.00M 10-Q · filed 2025-07-30 | $1.28B 10-Q · filed 2025-07-30 | $2.08B derived: sum of 3 quarters · filed 2026-04-29 | $2.76B derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $629.00M 10-Q · filed 2026-04-29 | $1.43B derived: sum of 2 quarters · filed 2026-04-29 | $2.11B derived: sum of 3 quarters · filed 2026-04-29 | $2.71B derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $801.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $1.48B derived: sum of 2 quarters · filed 2026-02-04 | $2.08B derived: sum of 3 quarters · filed 2026-02-04 | $2.63B 10-K · filed 2026-02-04 |
| 2024-09-30 | $676.00M 10-Q · filed 2025-10-29 | $1.28B derived: sum of 2 quarters · filed 2025-10-29 | $1.82B 10-Q · filed 2025-10-29 | $2.51B derived: sum of 4 quarters · filed 2026-02-04 |
| 2024-06-30 | $608.00M 10-Q · filed 2025-07-30 | $1.15B 10-Q · filed 2025-07-30 | $1.84B derived: sum of 3 quarters · filed 2026-02-04 | $2.45B derived: sum of 4 quarters · filed 2026-02-04 |
| 2024-03-31 | $540.00M 10-Q · filed 2025-04-30 | $1.23B derived: sum of 2 quarters · filed 2026-02-04 | $1.85B derived: sum of 3 quarters · filed 2026-02-04 | $2.42B derived: sum of 4 quarters · filed 2026-02-04 |
| 2023-12-31 | $689.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $1.31B derived: sum of 2 quarters · filed 2026-02-04 | $1.88B derived: sum of 3 quarters · filed 2026-02-04 | $2.44B 10-K · filed 2026-02-04 |
| 2023-09-30 | $617.00M 10-Q · filed 2024-10-30 | $1.19B derived: sum of 2 quarters · filed 2024-10-30 | $1.75B 10-Q · filed 2024-10-30 | $2.52B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $570.00M 10-Q · filed 2024-07-31 | $1.13B 10-Q · filed 2024-07-31 | $1.91B derived: sum of 3 quarters · filed 2025-02-13 | $2.51B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $559.00M 10-Q · filed 2024-04-30 | $1.34B derived: sum of 2 quarters · filed 2025-02-13 | $1.94B derived: sum of 3 quarters · filed 2025-02-13 | $2.57B derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $777.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $1.38B derived: sum of 2 quarters · filed 2025-02-13 | $2.01B derived: sum of 3 quarters · filed 2025-02-13 | $2.52B 10-K · filed 2025-02-13 |
| 2022-09-30 | $605.00M 10-Q · filed 2023-10-31 | $1.24B derived: sum of 2 quarters · filed 2023-10-31 | $1.75B 10-Q · filed 2023-10-31 | |
| 2022-06-30 | $631.00M 10-Q · filed 2023-07-25 | $1.14B 10-Q · filed 2023-07-25 | ||
| 2022-03-31 | $509.00M 10-Q · filed 2023-04-25 | |||
| 2021-12-31 | $2.79B 10-K · filed 2024-02-06 |